Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000254 · ClinicalTrials.gov registry record · Phase 2

Isoflurane at Subanesthetic Concentrations - 6

A Phase 2 study, sponsored by University of Chicago.

Completed
Registry status
Phase 2
Development phase
10
Enrollment target

NCT00000254 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000254, a Phase 2 study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
Phase 2
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To test the hypothesis that isoflurane at subanesthetic concentrations does not reduce cold-water immersion pain in healthy volunteers.

Interventions

  • OTHER Sham comparator
  • DRUG 0.2% isoflurane
  • DRUG 0.4% isoflurane
  • DRUG 40% Nitrous oxide
  • DRUG 0.6% isoflurane

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 1995-01
Est. Completion 1995-09
Phase Phase 2

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT00000254

The ClinicalTrials.gov registry entry for NCT00000254 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Sham comparator is the first listed.

NCT00000254 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00000254 about?

NCT00000254 is a clinical study titled "Isoflurane at Subanesthetic Concentrations - 6". The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To test the hypothesis that isoflurane at...

What is the current status of trial NCT00000254?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 1995-01. Estimated completion is 1995-09.

What interventions are being tested in trial NCT00000254?

The interventions under investigation include: Sham comparator (OTHER), 0.2% isoflurane (DRUG), 0.4% isoflurane (DRUG), 40% Nitrous oxide (DRUG), 0.6% isoflurane (DRUG).

Who is sponsoring clinical trial NCT00000254?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.